Evaluation and Treatment of Cortisol Levels
For suspected hypercortisolism (Cushing's syndrome), screen with late-night salivary cortisol (LNSC) or 1 mg overnight dexamethasone suppression test (DST), while for suspected adrenal insufficiency, measure morning cortisol with ACTH and confirm with cosyntropin stimulation testing if needed. 1, 2
Evaluation of Hypercortisolism (High Cortisol)
Screening Tests
Perform at least 2-3 late-night salivary cortisol (LNSC) measurements at usual bedtime (not necessarily midnight), as cortisol nadir is tightly entrained to sleep onset; values >3.6 nmol/L suggest Cushing's syndrome with 92% sensitivity 1, 3
Administer 1 mg dexamethasone orally at 11 PM and measure serum cortisol at 8 AM the following morning; cortisol <1.8 μg/dL (50 nmol/L) excludes Cushing's syndrome, while values >5 μg/dL (138 nmol/L) strongly suggest autonomous cortisol production 1, 2
Collect 24-hour urine free cortisol (UFC) on 2-3 separate occasions to account for day-to-day variability of up to 50%; this test is independent of cortisol-binding globulin changes but less reliable in renal impairment (CrCl <60 mL/min) 1
Confirmatory Testing
Measure plasma ACTH level to distinguish ACTH-dependent (pituitary or ectopic) from ACTH-independent (adrenal) causes of hypercortisolism 2, 4
Obtain adrenal CT imaging to characterize any adrenal mass; Hounsfield units <10 on non-contrast CT suggest benign adenoma 2
Screen for pheochromocytoma with plasma or 24-hour urinary metanephrines if Hounsfield units ≥10 before any intervention 2
Important Caveats
False-positive DST results occur with medications that induce CYP3A4 (phenobarbital, carbamazepine, St. John's wort), rapid dexamethasone absorption, or elevated cortisol-binding globulin from oral estrogens or pregnancy 1
LNSC should not be performed in night-shift workers due to disrupted circadian rhythm 1
Multiple sequential LNSC measurements are particularly useful for detecting cyclic Cushing's syndrome, where patients exhibit weeks to months of normal cortisol interspersed with hypercortisolism episodes 1
Evaluation of Adrenal Insufficiency (Low Cortisol)
Initial Assessment
Measure morning (8 AM) serum cortisol and plasma ACTH simultaneously in patients with unexplained collapse, hypotension, vomiting, diarrhea, hyperpigmentation, hyponatremia, hyperkalaemia, or hypoglycemia 1
Cortisol <250 nmol/L with elevated ACTH in acute illness is diagnostic of primary adrenal insufficiency; cortisol <400 nmol/L with elevated ACTH raises strong suspicion 1
Low ACTH with low cortisol indicates secondary (central) adrenal insufficiency from pituitary or hypothalamic dysfunction 1
Confirmatory Testing
Perform cosyntropin (ACTH) stimulation test when basal cortisol is equivocal (between 250-500 nmol/L): administer 0.25 mg tetracosactide IM or IV and measure cortisol at 30-60 minutes; peak cortisol <500 nmol/L confirms adrenal insufficiency 1, 5
For diagnostic testing with metyrapone, administer 30 mg/kg (maximum 3 grams) at midnight with food, then measure 11-deoxycortisol and ACTH at 7:30-8:00 AM; 11-deoxycortisol >70 mcg/L indicates intact HPA axis 6
Critical Pitfalls to Avoid
Never delay treatment for diagnostic testing in suspected acute adrenal crisis; give IV hydrocortisone 100 mg or dexamethasone 4 mg immediately 1
Morning cortisol is unreliable in patients currently taking corticosteroids; hydrocortisone must be held for 24 hours and other steroids longer before assessing endogenous function 1
ACTH stimulation testing can give false-negative results early in hypophysitis as adrenal reserve declines slowly after pituitary stimulation is lost 1
Patients on corticosteroids for other immune-related adverse events can develop isolated central adrenal insufficiency with low ACTH; test for HPA axis recovery after 3 months of maintenance therapy 1
Treatment of Hypercortisolism
Surgical Management (First-Line)
Transsphenoidal surgery is first-line treatment for pituitary Cushing's disease 4
Surgical removal of ectopic ACTH-producing tumors when resectable, or bilateral laparoscopic adrenalectomy for unresectable primary tumors 4
Medical Management
Ketoconazole 400-1200 mg/day for medical management of hypercortisolism when surgery is not feasible or as bridge to surgery 4
Mitotane for adrenal carcinoma 4
Octreotide for ectopic Cushing syndrome if tumor is Octreoscan-positive 4
Treatment of Adrenal Insufficiency
Primary Adrenal Insufficiency
Hydrocortisone 15-25 mg daily in divided doses (10-20 mg in morning, 5-10 mg in early afternoon); use lowest dose compatible with well-being 1, 4
Fludrocortisone 50-200 µg daily as single morning dose for mineralocorticoid replacement; adjust based on volume status, sodium level, and plasma renin activity 1, 4
Children require hydrocortisone 6-10 mg/m² body surface area daily 1
Secondary Adrenal Insufficiency
- Hydrocortisone 15-20 mg daily in divided doses (no fludrocortisone needed as mineralocorticoid function is preserved) 4
Acute Adrenal Crisis Management
Immediate IV hydrocortisone 100 mg plus at least 2 liters normal saline for volume resuscitation 1
Taper stress-dose corticosteroids to maintenance over 7-14 days after stabilization 1
For hypophysitis with severe symptoms: prednisone 1-2 mg/kg daily tapered over at least 1-2 weeks to physiologic maintenance 1
Stress Dosing and Special Situations
Double or triple maintenance glucocorticoid dose during illness or physical stress 4
Hydrocortisone 50-100 mg IV every 6-8 hours for initial stress dosing in hospitalized patients 1
Always start corticosteroids several days before thyroid hormone when treating multiple pituitary hormone deficiencies to prevent precipitating adrenal crisis 1
Essential Patient Education
All patients must wear medical alert bracelet/necklace identifying adrenal insufficiency 1, 4
Provide emergency injectable hydrocortisone with instructions for self-administration 1
Educate on stress dosing protocols and when to seek emergency care for impending adrenal crisis 1, 4
Endocrine consultation before surgery for stress-dose planning 1
Monitoring
Follow clinical symptoms and electrolytes regularly for dose adjustment 4
Retest HPA axis recovery at 3 months in patients with isolated central adrenal insufficiency after corticosteroid treatment for other conditions 1
For functioning tumors causing hypercortisolism: follow-up imaging and biomarkers every 3-6 months 4